CatNameSizePrice
BNC041648-100TIMP1 (Marker of Lymph Node Metastasis) (2A5), CF405S conjugate, 0.1mg/mL1x 100 µLAsk
LM801bLymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases/80 cores, replacing LM801a1 EachAsk
BNCB1943-500TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis) (rTIMP1/1710), Biotin conjugate, 0.1mg/mL1x 500 µLAsk
BNC741943-100TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis) (rTIMP1/1710), CF740 conjugate, 0.1mg/mL1x 100 µLAsk
NMET961Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961a1 EachAsk
MBS639683-01Tissue, Array, Human Adult Normal, Multi, tissue (8) III, Major Organ, Tonsil, Thymus, Appendix, Lymph node, Gallbladder, Prostate, Testis, Ovary (Paraffin)5 ArraysAsk
MBS639683-02Tissue, Array, Human Adult Normal, Multi, tissue (8) III, Major Organ, Tonsil, Thymus, Appendix, Lymph node, Gallbladder, Prostate, Testis, Ovary (Paraffin)5x 5 ArraysAsk
BNCB1944-100TIMP1 (Colorectal and Lymph Node Metastasis Marker) (TIMP1/1944R), Biotin conjugate, 0.1mg/mL1x 100 µLAsk
BNC941648-100TIMP1 (Marker of Lymph Node Metastasis) (2A5), CF594 conjugate, 0.1mg/mL1x 100 µLAsk
BNC401943-100TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis) (rTIMP1/1710), CF640R conjugate, 0.1mg/mL1x 100 µLAsk
BNC041944-100TIMP1 (Colorectal and Lymph Node Metastasis Marker) (TIMP1/1944R), CF405S conjugate, 0.1mg/mL1x 100 µLAsk
BNC941944-100TIMP1 (Colorectal and Lymph Node Metastasis Marker) (TIMP1/1944R), CF594 conjugate, 0.1mg/mL1x 100 µLAsk
BNC471648-500TIMP1 (Marker of Lymph Node Metastasis) (2A5), CF647 conjugate, 0.1mg/mL1x 500 µLAsk
BNCB1943-100TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis) (rTIMP1/1710), Biotin conjugate, 0.1mg/mL1x 100 µLAsk
BNC681648-100TIMP1 (Marker of Lymph Node Metastasis) (2A5), CF568 conjugate, 0.1mg/mL1x 100 µLAsk
ES1505Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores ( core size 1.5mm), replaced by ES1505a-ES1505eachAsk
MBS638077-01S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)0.01 mgAsk
MBS638077-02S100A11, Recombinant, Human, Western Blot Control (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C)5x 0.01 mgAsk
BR1005bBreast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a-BR1005beachAsk
LY800aLymphoma tissue array with normal lymph node tissue as control, 80 cases/ 80 cores, no overlapping with LY800b1 EachAsk
NCT186Paired Cancer and Normal Lymph node Paraffin Tissue (FFPE) Section5 Slides/PackAsk
ES810bEsophagus cancer with matched lymph node metastasis tissue array, including TNM and pathology grade, 40 cases/80 cores, replacing ES810a1 EachAsk
LY802Lymph node metastatic squamous cell carcinoma tissue arrayeachAsk
MBS8414791-01Human Lymph Node Tissue Lysate0.1 mgAsk
MBS8414791-02Human Lymph Node Tissue Lysate5x 0.1 mgAsk
MBS8414792-01Human Lymph Node Lysate Membrane Fraction0.1 mgAsk
MBS8414792-02Human Lymph Node Lysate Membrane Fraction5x 0.1 mgAsk
MBS6467304-01CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 750)0.1 mLAsk
MBS6467304-02CASC3, CT (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 750)5x 0.1 mLAsk
MBS6467306-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (AP)0.2 mLAsk
MBS6467306-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (AP)5x 0.2 mLAsk
MBS6467308-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Biotin)0.2 mLAsk
MBS6467308-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (Biotin)5x 0.2 mLAsk
MBS6467309-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (FITC)0.2 mLAsk
MBS6467309-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (FITC)5x 0.2 mLAsk
MBS6467311-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 405)0.1 mLAsk
MBS6467311-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 405)5x 0.1 mLAsk
MBS6467313-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 550)0.1 mLAsk
MBS6467313-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51) (MaxLight 550)5x 0.1 mLAsk
MBS6400042-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6400042-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk
MBS6400046-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6400046-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk
MBS6400048-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6400048-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk
MBS6400049-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6400049-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk
MBS6400051-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6400051-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk
MBS641329-01ERBB2, phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340)0.2 mLAsk
MBS641329-02ERBB2, phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340)5x 0.2 mLAsk
MBS6409523-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (AP)0.1 mLAsk
MBS6409523-02CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (AP)5x 0.1 mLAsk
MBS6409524-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (APC)0.1 mLAsk
MBS6409524-02CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (APC)5x 0.1 mLAsk
MBS6409527-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (HRP)0.1 mLAsk
MBS6409527-02CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (HRP)5x 0.1 mLAsk
MBS6409529-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (MaxLight 490)0.1 mLAsk
MBS6409529-02CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (MaxLight 490)5x 0.1 mLAsk
MBS6409530-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (MaxLight 550)0.1 mLAsk
MBS6409530-02CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (MaxLight 550)5x 0.1 mLAsk
MBS6383971-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (AP)0.1 mLAsk
MBS6383971-02KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (AP)5x 0.1 mLAsk
MBS6383972-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) APC0.1 mLAsk
MBS6383972-02KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) APC5x 0.1 mLAsk
MBS6397044-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M0.1 mLAsk
MBS6397044-02TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M5x 0.1 mLAsk
T201bLymphoma tissue array, with normal lymph node tissue, 6 cases/24 cores, replacing T201a1 EachAsk
MBS6373215-01CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (Biotin)0.1 mLAsk
MBS6373215-02CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (Biotin)5x 0.1 mLAsk
MBS6373223-01CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (PE)0.1 mLAsk
MBS6373223-02CD62L (L-selectin, Lymph Node Homing Receptor, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, TQ1, gp90-MEL, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, CD62 Antigen-like Family Member L, SELL, LYAM1, LNHR) (PE)5x 0.1 mLAsk
MBS6201583-01KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (MaxLight 490)0.1 mLAsk
MBS6201583-02KRT81 (Keratin, Type II Cuticular Hb1, Hair Keratin K2.9, Keratin, Hair, Basic, 1, Keratin-81, K81, Metastatic Lymph Node 137 Gene Protein, MLN 137, Type II Hair Keratin Hb1, Type-II Keratin Kb21, ghHKb1, ghHb1, KRTHB1, MLN137) (MaxLight 490)5x 0.1 mLAsk
MBS6203553-01STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (MaxLight 490)0.1 mLAsk
MBS6203553-02STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (MaxLight 490)5x 0.1 mLAsk
MBS6203122-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 490)0.1 mLAsk
MBS6203122-02S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 490)5x 0.1 mLAsk
MBS6212275-01LASP1 (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50) (MaxLight 550)0.1 mLAsk
MBS6212275-02LASP1 (LIM and SH3 Domain Protein 1, LASP-1, Metastatic Lymph Node Gene 50 Protein, MLN 50, MLN50) (MaxLight 550)5x 0.1 mLAsk
MBS6213797-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 550)0.1 mLAsk
MBS6213797-02S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 550)5x 0.1 mLAsk
MBS6214508-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M0.1 mLAsk
MBS6214508-02TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M5x 0.1 mLAsk
MBS6296185-01ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (APC)0.2 mLAsk
MBS6296185-02ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (APC)5x 0.2 mLAsk
MBS6296189-01ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLigh0.1 mLAsk
MBS6296189-02ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLigh5x 0.1 mLAsk
MBS6296190-01ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLigh0.1 mLAsk
MBS6296190-02ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLigh5x 0.1 mLAsk
MBS6296194-01ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (PE)0.2 mLAsk
MBS6296194-02ERBB2, CT (T1172/S1174) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (PE)5x 0.2 mLAsk
MBS6296208-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Biotin)0.2 mLAsk
MBS6296208-02ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Biotin)5x 0.2 mLAsk
MBS6296210-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Azide free) (HRP)0.2 mLAsk
MBS6296210-02ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Azide free) (HRP)5x 0.2 mLAsk
MBS6296212-01ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLight 490)0.1 mLAsk
MBS6296212-02ErbB2, NT (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (MaxLight 490)5x 0.1 mLAsk
MBS6296239-01ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296239-02ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296241-01ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (B0.2 mLAsk
MBS6296241-02ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (B5x 0.2 mLAsk
MBS6296242-01ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F0.2 mLAsk
MBS6296242-02ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F5x 0.2 mLAsk
MBS6296245-01ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296245-02ERBB2, Phosphorylated (S1151) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M5x 0.1 mLAsk
MBS6296286-01ERBB2, Phosphorylated (T1172) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F0.2 mLAsk
MBS6296286-02ERBB2, Phosphorylated (T1172) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F5x 0.2 mLAsk
MBS6296287-01ERBB2, Phosphorylated (T1172) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296287-02ERBB2, Phosphorylated (T1172) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296294-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296294-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296295-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296295-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296296-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (B0.2 mLAsk
MBS6296296-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (B5x 0.2 mLAsk
MBS6296297-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F0.2 mLAsk
MBS6296297-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (F5x 0.2 mLAsk
MBS6296299-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296299-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M5x 0.1 mLAsk
MBS6296303-01ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296303-02ERBB2, Phosphorylated (Y1005) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M5x 0.1 mLAsk
MBS6296316-01ERBB2, Phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296316-02ERBB2, Phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296317-01ERBB2, Phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A0.2 mLAsk
MBS6296317-02ERBB2, Phosphorylated (Y1127) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (A5x 0.2 mLAsk
MBS6296337-01ERBB2, Phosphorylated (Y1139) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (P0.2 mLAsk
MBS6296337-02ERBB2, Phosphorylated (Y1139) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (P5x 0.2 mLAsk
MBS6296358-01ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M0.1 mLAsk
MBS6296358-02ERBB2, Phosphorylated (Y1196) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (M5x 0.1 mLAsk
MBS6296398-01ERBB2, Phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Ma0.1 mLAsk
MBS6296398-02ERBB2, Phosphorylated (Y877) (ERBB2, HER2, MLN19, NEU, NGL, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340) (Ma5x 0.1 mLAsk
MBS627494-01C10orf27, CT (Protein SPATIAL, Stromal Protein Associated With Thymii And Lymph Node Homolog, SPATIAL)0.2 mLAsk
MBS627494-02C10orf27, CT (Protein SPATIAL, Stromal Protein Associated With Thymii And Lymph Node Homolog, SPATIAL)5x 0.2 mLAsk
MBS631325-01CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51)0.2 mLAsk
MBS631325-02CASC3 (Y181) (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, Protein MLN 51 Homolog, Protein Barentsz, Btz, mBtz, Protein CASC3, Mln51)5x 0.2 mLAsk
MBS6315263-01LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (Biotin)0.2 mLAsk
MBS6315263-02LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (Biotin)5x 0.2 mLAsk
MBS6315266-01LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (MaxLight 405)0.1 mLAsk
MBS6315266-02LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (MaxLight 405)5x 0.1 mLAsk
MBS6315270-01LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (MaxLight 750)0.1 mLAsk
MBS6315270-02LASP1, ID (LASP1, MLN50, LIM and SH3 domain protein 1, Metastatic lymph node gene 50 protein) (MaxLight 750)5x 0.1 mLAsk
MBS6268581-01CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T0.1 mLAsk
MBS6268581-02CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T5x 0.1 mLAsk
MBS6357895-01TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 405)0.1 mLAsk
MBS6357895-02TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 405)5x 0.1 mLAsk
MBS6357896-01TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 490)0.1 mLAsk
MBS6357896-02TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 490)5x 0.1 mLAsk
MBS6357899-01TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 750)0.1 mLAsk
MBS6357899-02TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (MaxLight 750)5x 0.1 mLAsk
MBS6235858-01TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M0.1 mLAsk
MBS6235858-02TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (M5x 0.1 mLAsk
MBS6243075-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (Biotin)0.1 mLAsk
MBS6243075-02ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (Biotin)5x 0.1 mLAsk
MBS6256791-01CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T0.1 mLAsk
MBS6256791-02CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T5x 0.1 mLAsk
MBS625790-01ErbB2, phosphorylated (Tyr1248) (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL)0.05 mgAsk
MBS625790-02ErbB2, phosphorylated (Tyr1248) (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL)5x 0.05 mgAsk
MBS6251635-01CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T0.1 mLAsk
MBS6251635-02CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LSEL, Leukocyte Adhesion Molecule 1, LAM1, Leukocyte Endothelial Cell Adhesion Molecule 1, LECAM1, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, T5x 0.1 mLAsk
MBS6252631-01CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, TQ1) (MaxLight 405)0.1 mLAsk
MBS6252631-02CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, TQ1) (MaxLight 405)5x 0.1 mLAsk
MBS6247724-01CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, TQ1) (AP)0.1 mLAsk
MBS6247724-02CD62L (gp90 MEL, hLHRc, L Selectin, L-Selectin, LECAM-1, Lymph Node Homing Receptor, LNHR, Lymphocyte Adhesion Molecule 1, LYAM1, PLNHR, Selectin L, SELL, TQ1) (AP)5x 0.1 mLAsk
MBS6235147-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 750)0.1 mLAsk
MBS6235147-02S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (MaxLight 750)5x 0.1 mLAsk
MBS6244646-01CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (PE)0.1 mLAsk
MBS6244646-02CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (PE)5x 0.1 mLAsk
MBS6136461-01ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) APC0.1 mLAsk
MBS6136461-02ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) APC5x 0.1 mLAsk
MBS6144189-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (Biotin)0.1 mLAsk
MBS6144189-02S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (Biotin)5x 0.1 mLAsk
MBS6149492-01S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (FITC)0.1 mLAsk
MBS6149492-02S100A11 (Protein S100-A11, S100 Calcium-binding Protein A11, Protein S100C, Calgizzarin,Metastatic Lymph Node Gene 70 Protein, MLN 70, S100C) (FITC)5x 0.1 mLAsk
MBS6149923-01STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (FITC)0.1 mLAsk
MBS6149923-02STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) (FITC)5x 0.1 mLAsk
MBS6139317-01STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) APC0.1 mLAsk
MBS6139317-02STARD3 (CAB1, MLN64, StAR-related Lipid Transfer Protein 3, Metastatic Lymph Node Gene 64 Protein, Protein CAB1, START Domain-containing Protein 3, FLJ41370) APC5x 0.1 mLAsk
MBS6141245-01CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2090.1 mLAsk
MBS6141245-02CLEC4M (C-type Lectin Domain Family 4 Member M, CD209 Antigen-like Protein 1, DC-SIGN-related Protein, DC-SIGNR, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2, DC-SIGN2, Liver/Lymph Node-specific ICAM-3-grabbing Non-integrin, L-SIGN, CD299, CD2095x 0.1 mLAsk